Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Fibrolamellar hepatocellular carcinoma × Surveys and Questionnaires × 90 days × Clear all

Sponsor

Conditions

Breast Neoplasms 21 Prostatic Neoplasms 9 Neoplasms 7 Multiple Myeloma 4 Lung Neoplasms 4 Rectal Neoplasms 3 Oropharyngeal Neoplasms 3 Neoplasm Metastasis 3 Lymphoma 3 Hematologic Neoplasms 3 Depression 3 Stomach Neoplasms 2 Sleep Apnea Syndromes 2 Pancreatic Neoplasms 2 Osteosarcoma 2 Motor Activity 2 Meningioma 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Health Behavior 2 Head and Neck Neoplasms 2 Gastrointestinal Neoplasms 2 Esophageal Neoplasms 2 Disease 2 Death 2 Colorectal Neoplasms, Hereditary Nonpolyposis 2 Colorectal Neoplasms 2 Chronic Pain 2 Carcinoma, Intraductal, Noninfiltrating 2 COVID-19 2 Brain Neoplasms 2

Interventions

Specimen Handling 2 Sorafenib 2 Irinotecan 2 poly ICLC 1 pembrolizumab 1 durvalumab 1 dehydroftorafur 1 atezolizumab 1 Watchful Waiting 1 Vincristine 1 Platinum 1 Oxaliplatin 1 Observation 1 Nivolumab 1 Ipilimumab 1 Gemcitabine 1 Fluorouracil 1 Etoposide 1 Doxorubicin 1 DT2216 1 Cyclophosphamide 1 Cisplatin 1 Carboplatin 1 Bevacizumab 1 1,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡